Inventor · disambiguated record
Jing Xiong
Also filed as: XIONG JING · XIONG JING-WEI
13 granted patents·6 pending applications·42 citations·filing 1998–2024
88Inventor score
Files withHOFFMANN LA ROCHE6BUSCHMANN NICOLE4NOVARTIS AG4BCEG ENV REMEDIATION CO LTD1GEN HOSPITAL CORP1
Top patents by PatentIndex Score
19 records- 0191US9533988B2Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsBUSCHMANN NICOLE·Filed 2015·Granted Jan 3, 2017·13 cites·8 claims
- 0290US9266883B2Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsBUSCHMANN NICOLE·Filed 2014·Granted Feb 23, 2016·16 cites·13 claims
- 0389US11873302B2Solid forms of a compound of HBV core protein allosteric modifierHOFFMANN LA ROCHE·Filed 2020·Granted Jan 16, 2024·2 cites·20 claims
- 0482US11230559B2Solid forms of [(1 S)-1 -[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-D]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-Yl]proptl] acetateHOFFMANN LA ROCHE·Filed 2018·Granted Jan 25, 2022·4 cites·13 claims
- 0578US10130629B2Pharmaceutical combinationsNOVARTIS AG·Filed 2016·Granted Nov 20, 2018·3 cites·7 claims
- 0678US9896449B2Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsBUSCHMANN NICOLE·Filed 2016·Granted Feb 20, 2018·2 cites·1 claims
- 0778US9802917B2Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamideBUSCHMANN NICOLE·Filed 2016·Granted Oct 31, 2017·2 cites·15 claims
- 0873US2024116941A1Solid forms of a hbv core protein allosteric modifierHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0970US10463653B2Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsNOVARTIS AG·Filed 2018·Granted Nov 5, 2019·0 cites·4 claims
- 1063US2024351921A1Method for preventing and treating pollution plume migration of permeable reactive barrierBCEG ENV REMEDIATION CO LTD·Filed 2024·Application pending·0 cites
- 1159US12012420B2Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetateHOFFMANN LA ROCHE·Filed 2021·Granted Jun 18, 2024·0 cites·16 claims
- 1259US12012421B2Solid forms of [(1S)-1-[(2S,4R,5R)-5-(5-amino-2-oxo-thiazolo[4,5-d]pyrimidin-3-yl)-4-hydroxy-tetrahydrofuran-2-yl]propyl] acetateHOFFMANN LA ROCHE·Filed 2021·Granted Jun 18, 2024·0 cites·13 claims
- 1357US2010047246A1Methods and Compositions for Treating Vascular DiseaseGEN HOSPITAL CORP·Filed 2007·Application pending·0 cites
- 1456US10507201B2Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitorsNOVARTIS AG·Filed 2019·Granted Dec 17, 2019·0 cites·17 claims
- 1549US2003167479A1Vascular endothelial zinc finger 1 gene and protein and uses thereofSINAI SCHOOL MEDICINE·Filed 2002·Application pending·0 cites
- 1646US2018185341A1Use of ring-fused bicyclic pyridyl derivatives as fgfr4 inhibitorsNOVARTIS AG·Filed 2015·Application pending·0 cites
- 1739US11866459B2Cocrystal of progesterone and preparation method and use thereofNAT INST FOOD & DRUG CONTROL·Filed 2021·Granted Jan 9, 2024·0 cites·11 claims
- 1839US11142534B2Process for the preparation of 3-substituted 5-amino-6H-thiazolo[4,5-d]pyrimidine-2,7-dione compoundsHOFFMANN LA ROCHE·Filed 2018·Granted Oct 12, 2021·0 cites·35 claims
- 1924US2002023277A1Vascular endothelial zinc finger 1 gene and protein and uses thereofFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jing Xiong files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →